Pfizer: Healthcare-Associated Pneumonia trials

The registry lists 11 Healthcare-Associated Pneumonia studies with Pfizer as lead sponsor. 1 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 1Phase 3 1Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in KoreaRecruitingNCT05733104
• Real-World Study of Ceftazidime Avibactam in ChinaTerminatedNCT05487586Results posted
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsCompletedNCT04882085Phase 4Results posted
• Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)CompletedNCT04774094Phase 4Results posted
• Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial PneumoniaTerminatedNCT04040621Phase 1Results posted
• A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial PneumoniaCompletedNCT01808092Phase 3Results posted
• Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or VancomycinCompletedNCT01561469Results posted
• Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired PneumoniaTerminatedNCT00707239Phase 2Results posted
• Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00084266Phase 4Results posted
• Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAPCompletedNCT02364284
• Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized PatientsCompletedNCT01363271